These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 2464055

  • 21. ATP-sensitive K+ channels from aortic smooth muscle incorporated into planar lipid bilayers.
    Kovacs RJ, Nelson MT.
    Am J Physiol; 1991 Aug; 261(2 Pt 2):H604-9. PubMed ID: 1715132
    [Abstract] [Full Text] [Related]

  • 22. Vasodilating actions of cromakalim in resting and contracting states of carotid arteries from spontaneously hypertensive rats.
    Asano M, Masuzawa-Ito K, Matsuda T.
    Eur J Pharmacol; 1994 Sep 22; 263(1-2):121-31. PubMed ID: 7529710
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the relaxing effects of cicletanine and cromakalim on vascular smooth muscle.
    Deitmer P, Golenhofen K, Noack T.
    J Cardiovasc Pharmacol; 1992 Jul 22; 20(1):35-42. PubMed ID: 1383629
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the in vitro effects of K+ channel modulators on detrusor and portal vein strips from guinea pigs.
    Zografos P, Li JH, Kau ST.
    Pharmacology; 1992 Jul 22; 45(4):216-30. PubMed ID: 1438528
    [Abstract] [Full Text] [Related]

  • 25. Endothelium-mediated and N omega-nitro-L-arginine methyl ester-sensitive responses to cromakalim and diazoxide in the rat mesenteric bed.
    Feleder EC, Adler-Graschinsky E.
    Eur J Pharmacol; 1997 Jan 29; 319(2-3):229-38. PubMed ID: 9042595
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein.
    Hamilton TC, Weir SW, Weston AH.
    Br J Pharmacol; 1986 May 29; 88(1):103-11. PubMed ID: 3708211
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers.
    Venkateswarlu K, Giraldi A, Zhao W, Wang HZ, Melman A, Spektor M, Christ GJ.
    J Urol; 2002 Jul 29; 168(1):355-61. PubMed ID: 12050569
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Relaxation by cromakalim and pinacidil of isolated smooth muscle cells from canine coronary artery-multiple sites of action.
    Rhim BY, Hong KW.
    Arch Int Pharmacodyn Ther; 1994 Jul 29; 328(1):67-81. PubMed ID: 7893192
    [Abstract] [Full Text] [Related]

  • 31. Charybdotoxin-sensitive K+ channels regulate the myogenic tone in the resting state of arteries from spontaneously hypertensive rats.
    Asano M, Masuzawa-Ito K, Matsuda T.
    Br J Pharmacol; 1993 Jan 29; 108(1):214-22. PubMed ID: 7679030
    [Abstract] [Full Text] [Related]

  • 32. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
    Cavero I, Mondot S, Mestre M.
    J Pharmacol Exp Ther; 1989 Mar 29; 248(3):1261-8. PubMed ID: 2495353
    [Abstract] [Full Text] [Related]

  • 33. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein.
    Masuda Y, Arakawa C, Yamashita T, Miyajima M, Shigenobu K, Kasuya Y, Tanaka S.
    Eur J Pharmacol; 1991 Apr 03; 195(3):323-31. PubMed ID: 1831135
    [Abstract] [Full Text] [Related]

  • 34. Potassium channel blockade and halothane vasodilation in conducting and resistance coronary arteries.
    Larach DR, Schuler HG.
    J Pharmacol Exp Ther; 1993 Oct 03; 267(1):72-81. PubMed ID: 8229789
    [Abstract] [Full Text] [Related]

  • 35. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
    Pratz J, Mondot S, Montier F, Cavero I.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):216-22. PubMed ID: 1906538
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
    Masuzawa K, Asano M, Matsuda T, Imaizumi Y, Watanabe M.
    J Pharmacol Exp Ther; 1990 Nov 01; 255(2):818-25. PubMed ID: 2123008
    [Abstract] [Full Text] [Related]

  • 38. Effects of SCA40 on human bronchi and on guinea pig main bronchi in vitro. Comparison with cromakalim.
    Naline E, Cui YY, Michel A, Bonnet PA, Bakdach H, Advenier C.
    Fundam Clin Pharmacol; 1996 Nov 01; 10(4):368-78. PubMed ID: 8871136
    [Abstract] [Full Text] [Related]

  • 39. Action of KC-399, a newly synthesized potassium channel opener, on mechanical activity and 86Rb efflux in rat aorta.
    Tamura K, Suzuki Y, Yoshida S, Nabata H.
    J Cardiovasc Pharmacol; 1994 Feb 01; 23(2):220-6. PubMed ID: 7511750
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro.
    Edwards G, Henshaw M, Miller M, Weston AH.
    Br J Pharmacol; 1991 Mar 01; 102(3):679-86. PubMed ID: 1364839
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.